FDA Inspection 1204740 — Agnieszka Zielinska, M.D., Ph.D.
The FDA completed an inspection of Agnieszka Zielinska, M.D., Ph.D. on Mar 31, 2023 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional Details
Clinical Investigator (CI)